NIRJA KAFLE: Open Payments
NPI 1578165486 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 14 payments from 5 companies in 2025. Trend: 2023 $18 · 2024 $379 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $168 |
| Novo Nordisk Inc | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: ZEPBOUND, MOUNJARO, Wegovy, JOURNAVX, XIFAXAN.
Industry payments across NM — which companies pay providers there.
